NCT06354556CompletedPhase 1
Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects
Effect of Verapamil on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects: a Single Center, Open, Single Arm, and Fixed Sequence Study
Source: ClinicalTrials.gov · Last updated 6 Jun 2024
Brief summary (registry, in English)
The purpose of this phase Ⅰ study is to evaluate the effect of oral verapamil tablets on the pharmacokinetics of HRS-1893 in healthy subjects.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 3 Apr 2024
- Start date
- 26 Apr 2024
- Primary completion date
- 20 May 2024
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT06354556
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 14
- From 26 Apr 2024 to the primary completion date, 20 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who have participated in any clinical trials and have taken study drugs within 3 months before the first administration.
Other illness
- History of persistent tachyarrhythmia and syncope.
- A history of stomach or bowel surgery or excision.
- Positive results of hepatitis B surface antigen, hepatitis C antibody, syphilis antibody and human immunodeficiency virus antibody.
Who the study is looking for
- Understand the study procedures and methods, voluntarily participate in the study, comply with study requirements, and sign the written informed consent form (ICF).
- Male or female aged 18-55（adult healthy volunteers).
- Body mass index (BMI) between 19 and 28 kg/m2.
- Normal Electrocardiogram (ECG).
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Anzhen Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.